The ransomware group 0apt has launched an attack on AdventHealth Group, compromising their healthcare administration and financial billing systems in the USA.
Ransomware Attacks, Data Breaches, and Threat Intelligence – All in One Stream.
Intel feeds
0apt Targets Legrand Building Infra in France
Legrand Building Infra, a leading French technology firm, has fallen victim to a ransomware attack by the notorious group 0apt. The attackers have reportedly accessed smart home hub source codes and electrical designs.
0apt Ransomware Attack on Bupa Global Health UK
Bupa Global Health (UK) has fallen victim to a ransomware attack orchestrated by the 0apt group. Sensitive policyholder databases and claim histories are at risk.
0apt Ransomware Attack on Magna Automotive Systems
On February 4, 2026, Magna Automotive Systems in Canada was targeted by the 0apt ransomware group, compromising supply chain logistics and automation code.
0apt Ransomware Attack on Mediclinic Middle East
The ransomware group 0apt has targeted Mediclinic Middle East, compromising private health insurance logs and staff PII. The attack has major implications for the UAE’s healthcare sector.
0apt Ransomware Attack on SMC Corporation Japan
The 0apt group has claimed responsibility for a ransomware attack on SMC Corporation in Japan, threatening to release sensitive pneumatic equipment and factory robotics data unless demands are met.
0apt Strikes Fresenius Medical Care with Ransomware Attack
Fresenius Medical Care, a prominent German healthcare company, has been targeted by the ransomware group 0apt. Sensitive data, including dialysis machine firmware and kidney research information, is at risk.
0apt Ransomware Attack on Sunnybrook Health Sciences
Sunnybrook Health Sciences, a leading Canadian hospital, has fallen victim to a ransomware attack by 0apt. The attacker threatens to release sensitive trauma center data unless demands are met.
0apt Ransomware Attack on Mayo Clinic
The Mayo Clinic has fallen victim to a ransomware attack by the 0apt group, placing sensitive cancer research and clinical trial data at risk of exposure.